Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in Canada
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Where
- Burnaby
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT05966467 - Phase 2Taking peopleStudy of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Where
- Toronto
- Age
- 2 years to 17 years
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT05549258 · EU 2023-510007-22-00